ERIS Lifesciences Ltd (ERIS) — Announcement | 7 September 2026

7 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

ERIS Lifesciences schedules analyst meeting with Bank of India Mutual Fund on September 10, 2026.

💡 Investor Takeaway

This meeting provides investors a chance to discuss ERIS's strategy and performance with management using only public data.

ERIS Lifesciences announced an analyst and institutional investor meeting scheduled for September 10, 2026, at 3:30 PM IST, conducted in person with Bank of India Mutual Fund, featuring Mr. Krishnakumar Vaidyanathan. The meeting is part of routine regulatory disclosure under SEBI LODR Regulation 30 and will reference only publicly available information without discussing any unpublished price sensitive information.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ERIS ✨ Ask AI About This

About ERIS Lifesciences Ltd (ERIS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹16,885.1 CrP/E: 25.9ROE: 16.5%ROCE: 13.6%Div Yield: 0.59%

View full ERIS stock details →

📡 Get AI alerts when ERIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ERIS — Free

💡 Ask AI about this filing

"How does ERIS's valuation compare to peers after this meeting?""What recent financial results support the discussed growth outlook?""Which risks were highlighted in the latest earnings call?"

Ask AI Free →

📊 More ERIS filings

Announcement — 28 September 2026ERIS Lifesciences announced that its trading window will close on October 1, 2026, and remain shut u...
🟡 Board Meeting — 25 September 2026ERIS Lifesciences held its 20th AGM on 25 September 2026 via video conference, approving audited fin...
🟡 Board Meeting — 25 September 2026ERIS Lifesciences held its 20th AGM on 25 September 2026 via video conference, approving the audited...
🔴 Corporate Action — 22 September 2026ERIS Lifesciences announced the allotment of 155,264 equity shares under its ESOP-2021 scheme on Sep...
🟡 Board Meeting — 21 September 2026ERIS Lifesciences announced the appointment of Akhil Awasthi as an additional non-executive independ...

See all ERIS filings →

🔥 Also filed on 7 September 2026

521036Source Industries (India) LtdAnnual Report 543578Olatech Solutions LtdAnnual Report 512025Asgard Alcobev LtdAnnual Report SIGACHISigachi Industries LtdCorporate Action 503675Wagend Infra Venture LtdAnnual Report 542864Mount Housing & Infrastructure LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ERIS files new disclosures

Track ERIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.